CONVATEC GRP PL/ADR (OTCMKTS:CNVVY) Downgraded by JPMorgan Chase & Co.

JPMorgan Chase & Co. cut shares of CONVATEC GRP PL/ADR (OTCMKTS:CNVVY) from a neutral rating to an underweight rating in a research note released on Monday morning, The Fly reports.

A number of other equities research analysts also recently commented on the stock. Royal Bank of Canada downgraded shares of CONVATEC GRP PL/ADR from an outperform rating to a sector perform rating in a report on Monday, December 9th. Sanford C. Bernstein assumed coverage on shares of CONVATEC GRP PL/ADR in a report on Tuesday, November 12th. They set an underperform rating for the company.

Shares of OTCMKTS CNVVY opened at $10.54 on Monday. CONVATEC GRP PL/ADR has a 12 month low of $6.03 and a 12 month high of $11.10. The company has a 50-day simple moving average of $10.39 and a 200-day simple moving average of $9.22.

CONVATEC GRP PL/ADR Company Profile

ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.

Featured Article: Most Volatile Stocks

The Fly

Receive News & Ratings for CONVATEC GRP PL/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONVATEC GRP PL/ADR and related companies with MarketBeat.com's FREE daily email newsletter.